Citations

Showing 10 of 108094 citations.

Autoimmune progesterone dermatitis: a retrospective case series
Aghazadeh, Nessa , Berry, Nicholas A. , Torgerson, Rochelle R. , Park, Miguel A., Davis, Dawn Marie R. , Aghazadeh Mohandesi, Nessa

Mayo Clinic

International Journal of Women’s Dermatology | July 8, 2022 | Volume: 8 | Issue: 3 | Pages: e009

10.1097/jw9.0000000000000009 | PMID 35822192 Get It

Background: Autoimmune progesterone dermatitis (APD) is a rare hypersensitivity disorder characterized by recurring dermatologic manifestations during the luteal phase of the menstrual cycle in women. Well-defined clinical and diagnostic criteria, outcomes measurements, and standard treatments are lacking. Methods: We performed a single-institution retrospective review of adult patients (older than 20 years at the time of diagnosis) with APD. Results: Fourteen patients were included with mean age of clinical onset of 34.3 ± 7.7 (range 24-54) years. There was a delay of 3.9 ± 5.5 (range 0.4-20) years between the onset of disease symptoms and diagnosis. The onset of APD was after exposure to exogenous progesterone in 9 of 14 patients. Progesterone skin test was performed in 9 patients and 6 were positive. Patients frequently presented with urticaria (9/14, 64.3%) and dermatitis (4/14, 28.6%). Continuous combined oral contraceptives (4/14, 28.6%), gonadotropin-releasing hormone agonist (3/14, 21.4%), and hysterectomy with bilateral salpingo-oophorectomy (2/14, 14.3%) were the most common attempted treatments with reliable outcomes. Conclusions: APD is a rare disorder which lacks universal diagnostic measures and criteria, contributing to a significant delay in diagnosis. Large-scale multicenter studies are needed to develop accurate tests, establish diagnostic criteria, and define treatment outcomes.
Shaping Cartilage Grafts
Ladd, Ryan, Fathizadeh, Sam, Fathi, Ramin, Fathizadeh, Sam

Mayo Clinic

Dermatologic Surgery | July 8, 2022 | Volume: 48 | Issue: 8 | Pages: 894-895

10.1097/dss.0000000000003515 | PMID 35917274 Get It

Brain radiotoxicity-related 15CAcBRT gene expression signature predicts survival prognosis of glioblastoma patients
Reyes-González, Jesús, Garcia‐Ortíz, Humberto , Magraner-Pardo, Lorena , Pons, Tirso , Aguirre‐Cruz, Lucinda, Reyes-Abrahantes, Andy, Martínez‐Hernández, Angélica , Contreras-Cubas, Cecilia , Quiñones‐Hinojosa, Alfredo , Abrahantes-Pérez, María del Carmen , Abrahantes-Pérez, María Del Carmen , Barajas-Olmos, Francisco Martin , Moreno‐Jiménez, Sergio , Barrios‐Payán, Jorge , Ruiz-García, Henry , Hernández‐Pando, Rogélio , Orozco, Lorena

Mayo Clinic

Neuro-Oncology | July 8, 2022 | Volume: 25 | Issue: 2 | Pages: 303-314

10.1093/neuonc/noac171 | PMID 35802478 Get It

Abstract Background Glioblastoma is the most common and devastating primary brain cancer. Radiotherapy is standard of care; however, it is associated with brain radiation toxicity (BRT). This study used a multi-omics approach to determine whether BRT-related genes (RGs) harbor survival prognostic value and whether their encoded proteins represent novel therapeutic targets for glioblastoma. Methods RGs were identified through analysis of single-nucleotide variants associated with BRT (R-SNVs). Functional relationships between RGs were established using Protein-Protein Interaction networks. The influence of RGs and their functional groups on glioblastoma prognosis was evaluated using clinical samples from the Glioblastoma Bio-Discovery Portal database and validated using the Chinese Glioma Genome Atlas dataset. The identification of clusters of radiotoxic and putative pathogenic variants in proteins encoded by RGs was achieved by computational 3D structural analysis. Results We identified the BRT-related 15CAcBRT molecular signature with prognostic value in glioblastoma, by analysis of the COMT and APOE protein functional groups. Its external validation confirmed clinical relevance independent of age, MGMT promoter methylation status, and IDH mutation status. Interestingly, the genes IL6, APOE, and MAOB documented significant gene expression levels alteration, useful for drug repositioning. Biological networks associated with 15CAcBRT signature involved pathways relevant to cancer and neurodegenerative diseases. Analysis of 3D clusters of radiotoxic and putative pathogenic variants in proteins coded by RGs unveiled potential novel therapeutic targets in neuro-oncology. Conclusions 15CAcBRT is a BRT-related molecular signature with prognostic significance for glioblastoma patients and represents a hub for drug repositioning and development of novel therapies.
Hemodynamic Responses to Provocative Maneuvers during Right Heart Catheterization
Montané, Bryce , Tonelli, Adriano R. , Arunachalam, Ambalavanan , Li, Manshi , Wang, Xiaofeng , Chaisson, Neal F. , Bhattacharyya, Anirban , Wang, Xiaofeng , Chaisson, Neal F , Tonelli, Adriano

Mayo Clinic

Annals of the American Thoracic Society | July 8, 2022 | Volume: 19 | Issue: 12 | Pages: 1977-1985

10.1513/annalsats.202201-077oc | PMID 35802812 Get It

Abstract Rationale Current guidelines recognize the utility of provocative maneuvers during right heart catheterization to aid the diagnosis of pulmonary hypertension. Few studies have compared the performance of different provocation maneuvers. Objectives To assess the hemodynamic correlation among three provocative maneuvers, including their effect on pulmonary hypertension classification. Methods This prospective trial was conducted between October 2016 and May 2018. Adult patients underwent three provocative maneuvers during right heart catheterization: passive leg raise (PLR), load-targeted supine bicycle exercise, and rapid crystalloid fluid infusion. Patients were classified as follows: no pulmonary hypertension, precapillary pulmonary hypertension, isolated postcapillary pulmonary hypertension, combined pre- and postcapillary pulmonary hypertension, and uncategorized pulmonary hypertension. We assessed the hemodynamic changes associated with each maneuver. We also assessed whether provocative maneuvers led to hemodynamic reclassification of the patient to either postcapillary pulmonary hypertension with provocation or exercise pulmonary hypertension. Results Eighty-five patients (mean age 62 ± 12 years, 53% women) were included. Correlation between exercise and fluid challenge was moderate to strong (0.49–0.82; P < 0.001) for changes in right atrial pressure, mean pulmonary arterial pressure, pulmonary arterial wedge pressure, and cardiac index from baseline. Correlation between PLR and exercise (0.4–0.65; P < 0.001) and between PLR and fluid challenge (0.45–0.6; P < 0.001) was moderate for changes in right atrial pressure, mean pulmonary arterial pressure, pulmonary arterial wedge pressure, pulmonary vascular resistance, and cardiac index. Hemodynamic correlation between other provocative maneuvers was poor. Depending on provocative maneuver and classification criteria, there was significant variation in the number of patients reclassified as having exercise pulmonary hypertension (3–50%) or postcapillary pulmonary hypertension with provocation (11–48%). Conclusions Hemodynamic determinations during exercise and fluid challenge showed moderate to strong hemodynamic correlation. Moderate hemodynamic correlation was seen between PLR and exercise or fluid challenge. Although some provocative maneuvers demonstrate good hemodynamic correlation, there is inconsistency when using these maneuvers to identify patients with postcapillary or exercise pulmonary hypertension.
The 100 Most-Cited and Influential Articles in Collegiate Athletics
Jenkins, Anna , Makovicka, Justin L. , Brinkman, Joseph C. , Jenkins, Anna S, Jenkins, Anna S , Pollock, Jordan Riley , Moore, M. Lane , Chhabra, Anikar

Mayo Clinic

Orthopaedic Journal of Sports Medicine | July 8, 2022 | Volume: 10 | Issue: 7 | Pages: No page available

10.1177/23259671221108401 | PMID 35837444 Get It

Background: Bibliometric citation analyses have been widely used in medicine to help researchers gain foundational knowledge about a topic and identify subtopics of popular interest for further investigations. There is a lack of similar research in collegiate athletics. Purpose: To identify the 100 most-cited research publications related to collegiate athletics. Study Design: Cross-sectional study. Methods: The Clarivate Analytics Web of Knowledge database was used to generate a list of articles relating to collegiate athletics on January 24, 2022. Articles were filtered by the total number of citations, and the 100 most-cited articles were selected. For each article, we identified and analyzed the following: author name, publication year, country of origin, journal name, article type, main research topic area, competitive level, sex of study population, and level of evidence. Results: Of the top 100 most-cited articles, 63 were related to medicine. In total, 96% of articles were published in the United States, and 80% were published in the year 2000 or later. Of the top 100 articles, 85 were observational; only 5 were experimental. The sport most represented was soccer, followed by football, baseball, and basketball. Of the top 100 articles, 21 were published in a single journal, the American Journal of Sports Medicine. Ten authors published ≥5 of the top 100 most-cited studies. Conclusion: The majority of top 100 articles were published in the United States after 1999 and primarily focused on medicine-related topics. Soccer was studied by more articles than football, baseball, and basketball. An author’s prestige may have influenced the likelihood of citation. The top 100 most-cited studies provide researchers, medical students, residents, and fellows with a foundational list of the most important and influential academic contributions to the literature on collegiate athletics.
Immune determinants of chronic sequelae after respiratory viral infection
Narasimhan, Harish , Wu, Yue , Goplen, Nick P., Sun, Jie , Goplen, Nicholas P , Sun, Jie

Mayo Clinic

Science Immunology | July 8, 2022 | Volume: 7 | Issue: 73 | Pages: No page available

10.1126/sciimmunol.abm7996 | PMID 35857581 Get It

The acute effects of various respiratory viral infections have been well studied, with extensive characterization of the clinical presentation as well as viral pathogenesis and host responses. However, over the course of the recent COVID-19 pandemic, the incidence and prevalence of chronic sequelae after acute viral infections have become increasingly appreciated as a serious health concern. Post-acute sequelae of COVID-19, alternatively described as “long COVID-19,” are characterized by symptoms that persist for longer than 28 days after recovery from acute illness. Although there exists substantial heterogeneity in the nature of the observed sequelae, this phenomenon has also been observed in the context of other respiratory viral infections including influenza virus, respiratory syncytial virus, rhinovirus, severe acute respiratory syndrome coronavirus, and Middle Eastern respiratory syndrome coronavirus. In this Review, we discuss the various sequelae observed following important human respiratory viral pathogens and our current understanding of the immunological mechanisms underlying the failure of restoration of homeostasis in the lung.
Response to Mitr and Pollack
Wickland, Daniel P. , Sherman, Mark E. , Mansfield, Aaron S. , Asmann, Yan W. , Radisky, Derek C. , Mansfield, Aaron S , Asmann, Yan W

Mayo Clinic

JNCI: Journal of the National Cancer Institute | July 8, 2022 | Volume: 114 | Issue: 12 | Pages: 1729-1730

10.1093/jnci/djac133 | PMID 35801929 Get It

Characterization of Secondary Interventions After Fenestrated-branched Endovascular Repair of Complex Aortic Aneurysms and Its Effect on Quality of Life and Patient Survival
Tenorio, Emanuel R. , Mirza, Aleem K. , Lima, Guilherme Baumgardt Barbosa , Wong, Joshua , Mendes, Bernardo C. , Saqib, Naveed, Khan, Sophia, Macedo, Thanila A. , Tenorio, Emanuel R , Lima, Guilherme B , Marcondes, Giulianna B. , Wong, Joshua, Oderich, Gustavo S.

Mayo Clinic

Annals of Surgery | July 8, 2022 | Volume: 278 | Issue: 1 | Pages: 140-147

10.1097/sla.0000000000005454 | PMID 35801701 Get It

Objective: To assess the impact of secondary intervention (SI) on health-related quality of life (HR-QOL) after fenestrated-branched endovascular aortic repair (FB-EVAR) for complex abdominal aortic aneurysms and thoracoabdominal aortic aneurysms. Background: The effect of SI after FB-EVAR on physical and mental HR-QOL has not been described. Methods: A cohort of 430 consecutive patients enrolled in a prospective, nonrandomized study to evaluate FB-EVAR (2013–2020) was assessed with 1325 short-form 36 HR-QOL questionnaires preoperatively and during follow-up visits. SIs were classified as major or minor procedures. Endpoints included patient survival, freedom from aortic-related mortality (ARM), freedom from SIs, and changes in HR-QOL physical component score (PCS) and mental component score. Results: There were 302 male with mean age 74±8 years treated by FB-EVAR for 133 complex abdominal aortic aneurysms and 297 thoracoabdominal aortic aneurysms. After a mean follow up of 26±20 months, 97 patients (23%) required 137 SIs. At 5 years, freedom from any SI was 64%±4%, including freedom from minor SIs of 77%±4% and major SIs of 87%±3%. There was no difference in patient survival and freedom from ARM at same interval. On adjusted analysis, minor SIs correlated with improved survival. SIs had a negative correlation with PCS (r=−0.8). There were no significant changes in mental component score with SIs. Predictors for SIs were fluoroscopy time, graft design, and aneurysm sac change. Conclusion: SIs were needed in nearly 1 out of 4 patients treated by FB-EVAR with no effect on patient survival or ARM. SI resulted in decline in PCS.
Updates in the Use of BCL-2-Family Small Molecule Inhibitors for the Treatment of Relapsed/Refractory Multiple Myeloma
Paulus, Aneel , Paulus, Aneel , Parrondo, Ricardo D , Ailawadhi, Sikander

Mayo Clinic

Cancers | July 8, 2022 | Volume: 14 | Issue: 14 | Pages: 3330

10.3390/cancers14143330 | PMID 35884390 Get It

Despite considerable advances in the treatment of multiple myeloma over the past decade, progression of disease is inevitable, and patients ultimately succumb to relapsed and refractory disease. Efficacious therapeutic regimens that target the key biological pathways that are essential for malignant plasma cell survival are necessary in the efforts to improve patient survival outcomes. The Bcl-2 family of proteins comprise oncogenes that promote myeloma cell survival by conferring resistance to apoptosis. These proteins are frequently upregulated in myeloma cells, thus making them attractive therapeutic targets. Several small molecule inhibitors of Bcl-2-family proteins are currently in clinical development for the treatment of relapsed/refractory multiple myeloma. Venetoclax, a Bcl-2-specific inhibitor, has generated the most clinical data and has shown promising results in patients with multiple myeloma harboring the t (11;14) translocation. Venetoclax has shown efficacy when combined with anti-CD38 monoclonal antibodies, immunomodulatory drugs, and proteasome inhibitors. Several other Bcl-2 inhibitors are in clinical development, as are inhibitors of Mcl-1, a Bcl-2-family oncoprotein that is perhaps more critical for myeloma cell survival than Bcl-2. This review will summarize the latest clinical data regarding the clinical development of Bcl-2-family protein inhibitors in the treatment of relapsed/refractory multiple myeloma.